• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阿尔茨海默病多基因风险对正常衰老认知衰退速度的影响。

Effects of polygenic risk for Alzheimer's disease on rate of cognitive decline in normal aging.

机构信息

Department of Integrative Medical Biologi, Umeå University, Umeå, Sweden.

Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.

出版信息

Transl Psychiatry. 2020 Jul 24;10(1):250. doi: 10.1038/s41398-020-00934-y.

DOI:10.1038/s41398-020-00934-y
PMID:32709845
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7381667/
Abstract

Most people's cognitive abilities decline with age, with significant and partly genetically driven, individual differences in rate of change. Although APOE ɛ4 and genetic scores for late-onset Alzheimer's disease (LOAD) have been related to cognitive decline during preclinical stages of dementia, there is limited knowledge concerning genetic factors implied in normal cognitive aging. In the present study, we examined three potential genetic predictors of age-related cognitive decline as follows: (1) the APOE ɛ4 allele, (2) a polygenic score for general cognitive ability (PGS-cog), and (3) a polygenic risk score for late-onset AD (PRS-LOAD). We examined up to six time points of cognitive measurements in the longitudinal population-based Betula study, covering a 25-year follow-up period. Only participants that remained alive and non-demented until the most recent dementia screening (1-3 years after the last test occasion) were included (n = 1087). Individual differences in rate of cognitive change (composite score) were predicted by the PRS-LOAD and APOE ɛ4, but not by PGS-cog. To control for the possibility that the results reflected a preclinical state of Alzheimer's disease in some participants, we re-ran the analyses excluding cognitive data from the last test occasion to model cognitive change up-until a minimum of 6 years before potential onset of clinical Alzheimers. Strikingly, the association of PRS-LOAD, but not APOE ɛ4, with cognitive change remained. The results indicate that PRS-LOAD predicts individual difference in rate of cognitive decline in normal aging, but it remains to be determined to what extent this reflects preclinical Alzheimer's disease brain pathophysiology and subsequent risk to develop the disease.

摘要

大多数人的认知能力会随着年龄的增长而下降,其变化速度存在显著的个体差异,部分受到遗传因素的影响。尽管 APOE ɛ4 等位基因和迟发性阿尔茨海默病(LOAD)的遗传评分与痴呆前阶段的认知能力下降有关,但对于正常认知衰老中涉及的遗传因素知之甚少。在本研究中,我们研究了三个可能的遗传预测因子与年龄相关的认知下降有关,如下所示:(1)APOE ɛ4 等位基因,(2)一般认知能力的多基因评分(PGS-cog),和(3)迟发性 AD 的多基因风险评分(PRS-LOAD)。我们在纵向人群基础的 Betula 研究中检查了六个时间点的认知测量,涵盖了 25 年的随访期。只有那些在最近的痴呆筛查中仍然存活且没有痴呆(在最后一次测试后 1-3 年)的参与者才被包括在内(n=1087)。认知变化率(综合评分)的个体差异由 PRS-LOAD 和 APOE ɛ4 预测,但不受 PGS-cog 预测。为了控制结果反映某些参与者的阿尔茨海默病临床前状态的可能性,我们排除了最后一次测试时的认知数据,重新分析了认知变化模型,直到潜在的临床阿尔茨海默病发病前至少 6 年。引人注目的是,PRS-LOAD 与认知变化的关联仍然存在,但 APOE ɛ4 则不然。结果表明,PRS-LOAD 可预测正常衰老过程中认知下降率的个体差异,但仍有待确定这在多大程度上反映了临床前阿尔茨海默病的大脑病理生理学以及随后发展为该病的风险。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c79/7381667/918b37e22374/41398_2020_934_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c79/7381667/918b37e22374/41398_2020_934_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c79/7381667/918b37e22374/41398_2020_934_Fig1_HTML.jpg

相似文献

1
Effects of polygenic risk for Alzheimer's disease on rate of cognitive decline in normal aging.阿尔茨海默病多基因风险对正常衰老认知衰退速度的影响。
Transl Psychiatry. 2020 Jul 24;10(1):250. doi: 10.1038/s41398-020-00934-y.
2
Utility of an Alzheimer's Disease Risk-Weighted Polygenic Risk Score for Predicting Rates of Cognitive Decline in Preclinical Alzheimer's Disease: A Prospective Longitudinal Study.阿尔茨海默病风险加权多基因风险评分预测临床前阿尔茨海默病认知下降率的效用:一项前瞻性纵向研究。
J Alzheimers Dis. 2018;66(3):1193-1211. doi: 10.3233/JAD-180713.
3
Alzheimer's disease genetic risk and changes in brain atrophy and white matter hyperintensities in cognitively unimpaired adults.认知未受损成年人的阿尔茨海默病遗传风险与脑萎缩及白质高信号的变化
Brain Commun. 2024 Aug 14;6(5):fcae276. doi: 10.1093/braincomms/fcae276. eCollection 2024.
4
A Network of Genetic Effects on Non-Demented Cognitive Aging: Alzheimer's Genetic Risk (CLU + CR1 + PICALM) Intensifies Cognitive Aging Genetic Risk (COMT + BDNF) Selectively for APOEɛ4 Carriers.遗传因素对非痴呆认知老化的影响网络:阿尔茨海默病遗传风险(CLU+CR1+PICALM)选择性增强 APOEɛ4 携带者的认知老化遗传风险(COMT+BDNF)。
J Alzheimers Dis. 2018;62(2):887-900. doi: 10.3233/JAD-170909.
5
Cognitive trajectories diverge by genetic risk in a preclinical longitudinal cohort.认知轨迹因临床前纵向队列中的遗传风险而异。
Alzheimers Dement. 2023 Jul;19(7):3108-3118. doi: 10.1002/alz.12920. Epub 2023 Feb 1.
6
APOE ɛ4, but not polygenic Alzheimer's disease risk, is related to longitudinal decrease in hippocampal brain activity in non-demented individuals.载脂蛋白 Eɛ4,但不是多基因阿尔茨海默病风险,与非痴呆个体中海马脑区活动的纵向下降有关。
Sci Rep. 2023 May 24;13(1):8433. doi: 10.1038/s41598-023-35316-z.
7
Cognitive Decline in Alzheimer's Disease: Limited Clinical Utility for GWAS or Polygenic Risk Scores in a Clinical Trial Setting.阿尔茨海默病认知衰退:GWAS 或多基因风险评分在临床试验环境中的临床应用有限。
Genes (Basel). 2020 May 2;11(5):501. doi: 10.3390/genes11050501.
8
Polygenic risk scores for Alzheimer's disease in relation to cognitive change: A representative sample from the general population followed over 16 years.多基因风险评分与阿尔茨海默病认知变化的关系:一项在一般人群中随访超过 16 年的代表性样本研究。
Neurobiol Dis. 2023 Dec;189:106357. doi: 10.1016/j.nbd.2023.106357. Epub 2023 Nov 15.
9
Butyrylcholinesterase K and Apolipoprotein E-ɛ4 Reduce the Age of Onset of Alzheimer's Disease, Accelerate Cognitive Decline, and Modulate Donepezil Response in Mild Cognitively Impaired Subjects.丁酰胆碱酯酶K和载脂蛋白E-ɛ4降低阿尔茨海默病的发病年龄,加速认知衰退,并调节轻度认知障碍受试者对多奈哌齐的反应。
J Alzheimers Dis. 2016 Oct 4;54(3):913-922. doi: 10.3233/JAD-160373.
10
Comparison of subjective cognitive decline and polygenic risk score in the prediction of all-cause dementia, Alzheimer's disease and vascular dementia.主观认知下降与多基因风险评分在预测全因痴呆、阿尔茨海默病和血管性痴呆中的比较。
Alzheimers Res Ther. 2024 Aug 19;16(1):188. doi: 10.1186/s13195-024-01559-9.

引用本文的文献

1
Education as a Modifier of Genetic Influence on Cognitive Ability in Older Adults.教育对老年人认知能力遗传影响的调节作用
Behav Genet. 2025 Aug 21. doi: 10.1007/s10519-025-10229-x.
2
Genetic Prοpensity for Different Aspects of Dementia Pathology and Cognitive Decline in a Community Elderly Population.社区老年人群痴呆病理不同方面及认知衰退的遗传倾向
Int J Mol Sci. 2025 Jan 22;26(3):910. doi: 10.3390/ijms26030910.
3
No effect of apolipoprotein E polymorphism on MRI brain activity during movie watching.载脂蛋白E基因多态性对观看电影时大脑磁共振成像活动无影响。

本文引用的文献

1
Associations of Amyloid, Tau, and Neurodegeneration Biomarker Profiles With Rates of Memory Decline Among Individuals Without Dementia.无痴呆症个体中淀粉样蛋白、tau 蛋白和神经退行性生物标志物特征与记忆下降速度的相关性。
JAMA. 2019 Jun 18;321(23):2316-2325. doi: 10.1001/jama.2019.7437.
2
Progress in Polygenic Composite Scores in Alzheimer's and Other Complex Diseases.多基因复合评分在阿尔茨海默病和其他复杂疾病中的研究进展。
Trends Genet. 2019 May;35(5):371-382. doi: 10.1016/j.tig.2019.02.005. Epub 2019 Mar 25.
3
Predicting Polygenic Risk of Psychiatric Disorders.
Brain Neurosci Adv. 2025 Jan 31;9:23982128251314577. doi: 10.1177/23982128251314577. eCollection 2025 Jan-Dec.
4
Non-APOE variants predominately expressed in smooth muscle cells contribute to the influence of Alzheimer's disease genetic risk on white matter hyperintensities.主要在平滑肌细胞中表达的非载脂蛋白E(APOE)变体,对阿尔茨海默病遗传风险对白质高信号的影响有作用。
Alzheimers Dement. 2025 Feb;21(2):e14455. doi: 10.1002/alz.14455. Epub 2024 Dec 31.
5
Brain change trajectories in healthy adults correlate with Alzheimer's related genetic variation and memory decline across life.健康成年人的大脑变化轨迹与阿尔茨海默病相关基因变异以及一生中的记忆力衰退相关。
Nat Commun. 2024 Dec 17;15(1):10651. doi: 10.1038/s41467-024-53548-z.
6
Revised Temperament and Character Inventory factors predict neuropsychiatric symptoms and aging-related cognitive decline across 25 years.修订后的气质与性格量表因素可预测25年间的神经精神症状及与衰老相关的认知衰退。
Front Aging Neurosci. 2024 Feb 21;16:1335336. doi: 10.3389/fnagi.2024.1335336. eCollection 2024.
7
Machine Learning Models of Polygenic Risk for Enhanced Prediction of Alzheimer Disease Endophenotypes.用于增强阿尔茨海默病内表型预测的多基因风险机器学习模型
Neurol Genet. 2024 Jan 10;10(1):e200120. doi: 10.1212/NXG.0000000000200120. eCollection 2024 Feb.
8
Modern Approaches to the Diagnosis of Cognitive Impairment and Alzheimer's Disease: A Narrative Literature Review.认知障碍和阿尔茨海默病诊断的现代方法:叙述性文献综述
Consort Psychiatr. 2023 Mar 31;4(1):53-62. doi: 10.17816/CP716.
9
Digital Clock Drawing as an Alzheimer's Disease Susceptibility Biomarker: Associations with Genetic Risk Score and APOE in Older Adults.数字时钟绘画作为阿尔茨海默病易感性生物标志物:与老年人遗传风险评分和载脂蛋白E的关联
J Prev Alzheimers Dis. 2024;11(1):79-87. doi: 10.14283/jpad.2023.48.
10
Proof-of-concept recall-by-genotype study of extremely low and high Alzheimer's polygenic risk reveals autobiographical deficits and cingulate cortex correlates.极低和极高阿尔茨海默病多基因风险的基于基因型的记忆再现概念验证研究揭示了自传体记忆缺陷和扣带回皮层的相关性。
Alzheimers Res Ther. 2023 Dec 12;15(1):213. doi: 10.1186/s13195-023-01362-y.
预测精神障碍的多基因风险。
Biol Psychiatry. 2019 Jul 15;86(2):97-109. doi: 10.1016/j.biopsych.2018.12.015. Epub 2018 Dec 28.
4
Gene discovery and polygenic prediction from a genome-wide association study of educational attainment in 1.1 million individuals.从一项涉及 110 万人的教育程度全基因组关联研究中发现基因并进行多基因预测。
Nat Genet. 2018 Jul 23;50(8):1112-1121. doi: 10.1038/s41588-018-0147-3.
5
Successful Memory Aging.成功的记忆老化。
Annu Rev Psychol. 2019 Jan 4;70:219-243. doi: 10.1146/annurev-psych-010418-103052. Epub 2018 Jun 27.
6
Effects of amyloid pathology and neurodegeneration on cognitive change in cognitively normal adults.淀粉样蛋白病理和神经退行性变对认知正常成年人认知变化的影响。
Brain. 2018 Aug 1;141(8):2475-2485. doi: 10.1093/brain/awy150.
7
Dissociable influences of ε4 and polygenic risk of AD dementia on amyloid and cognition.AD 痴呆症的 ε4 和多基因风险对淀粉样蛋白和认知的可分离影响。
Neurology. 2018 May 1;90(18):e1605-e1612. doi: 10.1212/WNL.0000000000005415. Epub 2018 Mar 28.
8
Use of an Alzheimer's disease polygenic risk score to identify mild cognitive impairment in adults in their 50s.使用阿尔茨海默病多基因风险评分识别 50 多岁成年人的轻度认知障碍。
Mol Psychiatry. 2019 Mar;24(3):421-430. doi: 10.1038/s41380-018-0030-8. Epub 2018 Feb 27.
9
Alzheimer's disease CSF biomarkers: clinical indications and rational use.阿尔茨海默病脑脊液生物标志物:临床指征与合理应用。
Acta Neurol Belg. 2017 Sep;117(3):591-602. doi: 10.1007/s13760-017-0816-5. Epub 2017 Jul 27.
10
Impact of multiple pathologies on the threshold for clinically overt dementia.多种病变对临床显性痴呆阈值的影响。
Acta Neuropathol. 2017 Aug;134(2):171-186. doi: 10.1007/s00401-017-1717-7. Epub 2017 May 9.